Minimally Invasive Surgery Using Polymer-Based Coil Sets New Standard in Treatment
In a groundbreaking medical achievement, a woman in Delaware has become the first patient to receive minimally invasive endovascular surgery utilizing a new polymer-based coil. This procedure was facilitated by the pioneering medical device company, Embolization, Inc., which has designed the coil to enhance safety and efficacy in vascular embolization procedures.
The newly developed coil is particularly aimed at treating complex conditions such as pelvic varices, which often lead to chronic pelvic pain—known as pelvic congestion syndrome. The treatment was conducted by Dr. Mark J. Garcia at EndoVascular Consultants, a facility renowned for its specialized interventional radiology procedures. Dr. Garcia expressed optimism about the coil's advantages, noting that it significantly reduces imaging artifacts which are commonly seen with traditional metal coils during CT scans or MRIs.
The polymer-based coil, known as the Nitinol Enhanced Device (NED), marked its significant milestone when it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) earlier this summer. Unlike conventional embolic devices that can produce considerable artifacts in imaging, the NED is made from proprietary shape-memory biocompatible polymers. This innovative design not only improves the quality of vascular occlusion but also keeps artifacts to a minimum—effectively allowing for clearer imaging and diagnosis.
Jim Kasic, the CEO of Embolization, Inc., commented on the transformative nature of the NED, emphasizing how this coil performs all the functions of traditional metal coils but offers added benefits in terms of imaging clarity and patient safety. The coil remains radiopaque under fluoroscopy, ensuring adequate visibility during procedures.
The implications of this advancement are extensive. By minimizing artifacts in imaging, it allows for better evaluation and management of vascular conditions. It is anticipated that the NED will lead to more accurate diagnoses, better treatment planning, and ultimately improved outcomes for patients suffering from venous conditions. Additionally, the design and manufacturing of this coil are indicative of a shift towards using biocompatible materials in medical devices, a trend that prioritizes both patient safety and the effectiveness of medical interventions.
This first successful surgery with the polymer-based coil opens the door for further innovation in the field of vascular treatments, as hospitals and clinics may begin to adopt these devices for various applications. With further studies, the full capabilities of the NED could be explored, potentially expanding its uses beyond pelvic conditions to a broader scope of vascular problems.
Embolization, Inc. has positioned itself as a leader in creating minimally invasive devices that leverage modern technologies to enhance patient care. As more healthcare facilities take notice of the advantages offered by polymer coils, the evolution of embolization procedures may well be underway, setting a new benchmark in the treatment and management of vascular disorders.
For more information about the NED and other products from Embolization, Inc., visit their website at www.embolizationinc.com.
The newly developed coil is particularly aimed at treating complex conditions such as pelvic varices, which often lead to chronic pelvic pain—known as pelvic congestion syndrome. The treatment was conducted by Dr. Mark J. Garcia at EndoVascular Consultants, a facility renowned for its specialized interventional radiology procedures. Dr. Garcia expressed optimism about the coil's advantages, noting that it significantly reduces imaging artifacts which are commonly seen with traditional metal coils during CT scans or MRIs.
The polymer-based coil, known as the Nitinol Enhanced Device (NED), marked its significant milestone when it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) earlier this summer. Unlike conventional embolic devices that can produce considerable artifacts in imaging, the NED is made from proprietary shape-memory biocompatible polymers. This innovative design not only improves the quality of vascular occlusion but also keeps artifacts to a minimum—effectively allowing for clearer imaging and diagnosis.
Jim Kasic, the CEO of Embolization, Inc., commented on the transformative nature of the NED, emphasizing how this coil performs all the functions of traditional metal coils but offers added benefits in terms of imaging clarity and patient safety. The coil remains radiopaque under fluoroscopy, ensuring adequate visibility during procedures.
The implications of this advancement are extensive. By minimizing artifacts in imaging, it allows for better evaluation and management of vascular conditions. It is anticipated that the NED will lead to more accurate diagnoses, better treatment planning, and ultimately improved outcomes for patients suffering from venous conditions. Additionally, the design and manufacturing of this coil are indicative of a shift towards using biocompatible materials in medical devices, a trend that prioritizes both patient safety and the effectiveness of medical interventions.
This first successful surgery with the polymer-based coil opens the door for further innovation in the field of vascular treatments, as hospitals and clinics may begin to adopt these devices for various applications. With further studies, the full capabilities of the NED could be explored, potentially expanding its uses beyond pelvic conditions to a broader scope of vascular problems.
Embolization, Inc. has positioned itself as a leader in creating minimally invasive devices that leverage modern technologies to enhance patient care. As more healthcare facilities take notice of the advantages offered by polymer coils, the evolution of embolization procedures may well be underway, setting a new benchmark in the treatment and management of vascular disorders.
For more information about the NED and other products from Embolization, Inc., visit their website at www.embolizationinc.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.